FDA to restructure drug review staff

On Friday, FDA unveiled plans to reorganize its review of new drugs. A set of organizational changes, slated to take effect in the spring of 2005,

Read the full 266 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE